Psychotic Disorders Program
Overview
This program supports research leading to a fuller understanding of the causes, neurobiology, phenotypes, and effective treatments for schizophrenia and other psychotic disorders.
Areas of Emphasis
- Physiological risk factors for schizophrenia and psychosis.
- Neurofunctional correlates of thought disorder and psychosis.
- Development of novel pharmacological interventions for childhood psychotic disorders including predictors of treatment response.
- Development of psychosocial interventions aimed at optimizing adaptive functioning of children and adolescents with psychotic disorders.
Contact
Ann E. Wagner, Ph.D.
Program Chief
6001 Executive Boulevard, Room 7149, MSC 9633
301-443-3633, awagner@mail.nih.gov
